Share-Based Plans (Details) (USD $) | 3 Months Ended | |
3-May-14 | 4-May-13 | Feb. 01, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Share-based Compensation Expense | $2,800,000 | $4,600,000 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' |
Weighted-average fair value of stock options granted | ' | $12.14 | ' |
Risk-free interest rate | ' | 0.70% | ' |
Expected life (years) | ' | '4 years 2 months 12 days | ' |
Expected volatility | ' | 42.50% | ' |
Expected annual forfeiture rate | ' | 3.00% | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | ' | ' |
Outstanding stock options, beginning balance | 3,377,303 | ' | ' |
Granted | 0 | ' | ' |
Exercised | -243,218 | ' | ' |
Forfeited | -139,850 | ' | ' |
Outstanding stock options, ending balance | 2,994,235 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Options, Vested and Expected to Vest, Outstanding, Number | 2,981,614 | ' | ' |
Options, Exercisable, Number | 1,839,422 | ' | ' |
Options, Outstanding, Weighted Average Exercise Price | $35.35 | ' | $34.88 |
Options, Grants in Period, Weighted Average Exercise Price | $0 | ' | ' |
Options, Exercises in Period, Weighted Average Exercise Price | $26.90 | ' | ' |
Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | $38.63 | ' | ' |
Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | $35.25 | ' | ' |
Options, Exercisable, Weighted Average Exercise Price | $33.67 | ' | ' |
Options, Outstanding, Weighted Average Remaining Contractual Term | '4 years 2 months 24 days | ' | ' |
Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | '4 years 2 months 18 days | ' | ' |
Options, Exercisable, Weighted Average Remaining Contractual Term | '3 years 4 months 24 days | ' | ' |
Options, Outstanding, Intrinsic Value | 16,314,000 | ' | ' |
Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | 16,053,000 | ' | ' |
Options, Exercisable, Intrinsic Value | 13,141,000 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Total intrinsic value of stock options exercised | 2,588,000 | 1,040,000 | ' |
Total fair value of restricted stock vested | 523,000 | 0 | ' |
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized | $45,000,000 | ' | ' |
Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition | '2 years 5 months 18 days | ' | ' |
Stock Options [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Award Requisite Service Period | '4 years | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Term | '7 years | ' | ' |
Restricted Stock [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' |
Nonvested, beginning balance | 664,101 | ' | ' |
Granted | 281,056 | ' | ' |
Vested | -13,500 | ' | ' |
Forfeited | -99,200 | ' | ' |
Nonvested, ending balance | 832,457 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Nonvested, Weighted Average Grant Date Fair Value | $37.77 | ' | $38.34 |
Grants in Period, Weighted Average Grant Date Fair Value | $37.12 | ' | ' |
Vested in Period, Weighted Average Grant Date Fair Value | $34.75 | ' | ' |
Forfeited in Period, Weighted Average Grant Date Fair Value | $40.19 | ' | ' |
Restricted Stock Awards (RSAs) [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Award Requisite Service Period | '5 years | ' | ' |
Restricted Stock Awards (RSAs) [Member] | Current [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Award Vesting Period | '5 years | ' | ' |
Restricted Stock Units (RSUs) [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Award Requisite Service Period | '3 years | ' | ' |
Performance Shares [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | 434,643 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Award Vesting Period | '3 years | ' | ' |
CEO Performance Share Units [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Term | '7 years | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' |
Nonvested, beginning balance | 37,800 | ' | ' |
Nonvested, ending balance | 37,800 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Nonvested, Weighted Average Grant Date Fair Value | ' | ' | $34.68 |